Skip to main content

Table 2 Candidate genes

From: Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patients

GENE

MEDIAN RPKM in ccRCC (based on expression data from TCGA consortium, [31])

FOLD DIFFERENCE, median rpkm in ccRCC vs. median rpkm in normal kidney (based on expression data from TCGA consortium, [31])

RPKM DISTRIBUTION DISTANCE,

5th percentile ccRCC/ 95th percentile normal kidney (based on expression data from TCGA consortium, [31])

BLOOD RPKM value of 95th percentile (based on GEO database [34])

BLOOD RPKM value of 95th percentile (based on GTEx database [35])

NDUFA4L2

701

145

1.06

0.16

0.15

EGLN3

174

23.2

0.93

0.72

0.62

CA9

117

1218

3.74

1

0.13

CCND1

138

4.34

0.58

0.58

0.37

CAV2

110

3.98

0.69

0.43

0.43

ESM1

92.5

12.4

0.6

0.77

0.2

PPP1R3C

20.1

3.66

0.54

0.03

0.67

STC2

19.1

22.3

1.33

0

0.07

NPTX2

18.4

150

1.48

0.07

0.13

ANGPT2

17.1

10.4

0.54

0.11

0.08

DGCR5

15.2

25.9

0.99

0.3

0.17

DOCK6

13.2

2.08

0.51

0.26

0.68

FABP6

11.9

91.3

1.18

0.62

0.85

TMEM133

8.9

2.67

0.52

0.60

0.24

LZTS1

8.81

5.54

0.52

0.26

0.25

COX4I2

6.85

4.37

0.52

0.06

0.15

KIAA1274

6.71

4.11

0.58

0.78

0.41

LPIN3

6.14

2.29

0.54

0.12

0.17

FKBP9L

6.11

1.32

0.51

0.71

0.14

RAB42

5.90

5.47

1.02

0.17

0.49

MET

112

2.08

0.36

0.07

0.1

CDK18

85.4

5.29

0.28

1.21

0.85

CP

79.7

21.3

0.11

0.89

0.4

TMEM45A

62.9

2.43

0.71

0.13

2.31

LOX

51.0

10.8

0.22

0.22

0.29

GAL3ST1

49.4

8.14

0.3

0.15

0.11

CYP2J2

49

39.3

0.27

0.65

0.2

NOL3

44.1

10.6

1.36

1.98

2.47

FBXO17

38.7

2.77

0.5

2

0.12

FABP7

19.9

974

0.22

0

0.05

BARX2

19.1

6.01

0.27

0.42

0.04